• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transbound Emerg Dis . Outcomes and prognostic factors in 70 non-survivors and 595 survivors with COVID-19 in Wuhan, China

tetano

Editor, Senior Moderator
Transbound Emerg Dis


. 2020 Dec 30.
doi: 10.1111/tbed.13969. Online ahead of print.
Outcomes and prognostic factors in 70 non-survivors and 595 survivors with COVID-19 in Wuhan, China


Mingyu Liu[SUP] 1 [/SUP], Shuolong Han[SUP] 2 [/SUP], Qiaohong Liao[SUP] 3 [/SUP], Liping Chang[SUP] 2 [/SUP], Yunzhe Tan[SUP] 1 [/SUP], Pingping Jia[SUP] 3 [/SUP], Libo Yang[SUP] 2 [/SUP], Hongbin Cai[SUP] 1 [/SUP], Shaolun Feng[SUP] 3 [/SUP], Can Chen[SUP] 3 [/SUP], Shi Zhang[SUP] 3 [/SUP], Zhenhua Jia[SUP] 2 4 [/SUP], Jian Yi[SUP] 1 [/SUP]



Affiliations

Abstract

Since first outbreak of coronavirus disease 2019 (COVID-19) occurred in December 2019, more than 51 millions cases had been reported globally. We aimed to identify the risk factors for in-hospital fatal outcome and severe pneumonia of this disease.This is a retrospective, multicentre study, which included all confirmed cases of COVID-19 with definite outcomes (died or discharged) hospitalized between January 1[SUP]st[/SUP] and March 4[SUP]th[/SUP] 2020 in Wuhan. Of all 665 patients included: 70 died, 595 discharged (including 333 mild and 262 severe cases). Underlying comorbidity was more commonly observed among deaths (72.9%) than mild (26.4%) and severe (61.5%) survivors, with hypertension, diabetes and cardiovascular as dominant diseases. Fever and cough were the primary clinical magnifications. Older age (≥ 65 years) (OR=3.174, 95% CI=1.356-7.755), diabetes (OR=2.540, 95% CI=0.995-6.377), dyspnea (OR=7.478, 95% CI=3.031-19.528), respiratory failure (OR=10.528, 95% CI= 4.484-25.829), acute cardiac injury (OR=25.103, 95% CI=9.057-76.590), and acute respiratory distress syndrome (OR=7.308, 95% CI=1.501-46.348) were associated with in-hospital fatal outcome. In addition, older age (OR=2.149, 95% CI=1.424-3.248), diabetes (OR=3.951, 95% CI=2.077-7.788), cardiovascular disease (OR=3.414, 95% CI=1.432-8.799), nervous system disease (OR=4.125, 95% CI=1.252-18.681), dyspnea (OR=31.944, 95% CI=18.877-92.741), achieving highest in-hospital temperature of >39.0℃ (OR=37.450, 95% CI=7.402-683.403), and longer onset of illness to diagnosis (≥ 9 days) were statistically associated with higher risk of developing severe COVID-19. In conclusion, the potential risk factors of older age, diabetes, dyspnea, respiratory failure, acute cardiac injury and acute respiratory distress syndrome could help clinicians to identify patients with poor prognosis at an early stage.

Keywords: 2019 novel coronavirus; acute respiratory disease; fatality; prognosis.
 
Back
Top Bottom